The chr20p13 genomic deletion spans multiple genes (Supplementary Table S2), including RBCK1, whose reduced expression has been shown to be associated with increased tumor cell proliferation and survival, as well as with poor prognosis in breast cancer (Donley et al., 2014). The gene discussed is RBCK1; the disease is breast carcinoma.